Immunogen reported $0 in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agios Pharmaceuticals AGIO:US USD 1.14M 84K
Amgen AMGN:US USD 38.7B 2.18B
Astellas Pharma 4503:JP JPY 288B 30.1B
AstraZeneca AZN:LN USD 29.3B 229M
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Eli Lilly And LLY:US USD 15.89B 925.4M
Emergent Biosolutions EBS:US USD 1.05B 228.1M
Halozyme Therapeutics HALO:US USD 1.5B 258.29M
Heron Therapeutics HRTX:US USD 149.23M 52K
Intrexon XON:US USD 82.07M 116.6M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Novartis NVS:US USD 28.44B 2.59B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K